A5071328222- Advanced Radiotherapy Techniques
- Breast Cancer Treatment Studies
- Advanced X-ray and CT Imaging
- MRI in cancer diagnosis
- Lung Cancer Diagnosis and Treatment
- Breast Implant and Reconstruction
- Medical Imaging Techniques and Applications
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
Shandong First Medical University
2019-2024
Shandong Tumor Hospital
2019-2024
Shandong University
2019
Abstract Background This study investigated the differences in target volumes between preoperative magnetic resonance imaging (MRIpre) and postoperative MRI (MRIpost) for breast radiotherapy after breast‐conserving surgery (BCS) using deformable image registration (DIR). Methods Materials Seventeen eligible patients who underwent whole‐breast irradiation prone position BCS were enrolled. On MRIpre, gross tumor volume (GTV) was delineated as GTVpre, which then expanded by 10 mm to represent...
Objective: To compare differences in setup error assessment and correction between planar kilovolt images cone beam computed tomography for external partial breast irradiation during free breathing. Methods: Nineteen patients who received after breast-conserving surgery were recruited. Interfraction was acquired using tomography. After online correction, the residual calculated, compared. The margin quantified images. Results: largest observed anteroposterior direction both imaging (−1.45...
To evaluate the incidental coverage dose to internal mammary nodes (IMN) in patients treated with postmastectomy radiotherapy (PMRT) and its relationship treatment plan.We retrospectively analyzed 138 undergoing PMRT divided them into three groups: three-dimensional conformal (3D-CRT), field-in-field forward intensity-modulated (F-IMRT), inverse (I-IMRT). The IMN were contoured according Radiation Therapy Oncology Group consensus not included planning target volume. We lung heart.The mean...
The aim of this study was to investigate the role local radiotherapy in management epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancers (NSCLCs) treated with EGFR tyrosine kinase inhibitors (TKIs).Patients stage IV EGFR-mutant NSCLC concomitant TKIs from May 2010 December 2017 were retrospectively identified. Overall survival (OS) primary endpoints study.A total 205 patients enrolled study. One hundred eleven received one-time single-site (SSR), and 94 multiple-site...